HONG KONG, April 15 (Reuters) - Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 ...

Med-X has already acquired the ticker "MXRX" for their planned NASDAQ listing. Since going public could present an opportunity for higher visibility for the brand and possible greater liquidity for ...

The SME IPO, valued at ₹27 crore, was open for subscription from June 20, 2025, to June 24, 2025, with a price band of ₹72 per share. The issue is entirely fresh issue of 37.50 lakh shares with no ...

Leading Organic Trade Organization Lists Nature-Cide All-Purpose Commercial Concentrate as Allowed for the Use in Accordance with the National Organic Program (NOP) Standards for use Cases in ...